Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

EndeavorRx

K-Number: K231337 · 2023-12-13

Decision Date2023-12-13
Product CodeQFT
Advisory CommitteeOB
DecisionSubstantially Equivalent

Device Summary

EndeavorRx is a medical device manufactured by Akili Interactive Labs, Inc.. It received FDA 510(k) clearance on 2023-12-13 under approval number K231337. The device is classified under product code QFT. It was reviewed by the OB advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the EndeavorRx?

EndeavorRx is a medical device that received FDA 510(k) clearance on 2023-12-13. It is manufactured by Akili Interactive Labs, Inc.. The 510(k) number is K231337.

When was EndeavorRx approved by the FDA?

EndeavorRx received FDA 510(k) clearance on 2023-12-13, under approval number K231337.

What company makes EndeavorRx?

EndeavorRx is manufactured by Akili Interactive Labs, Inc..

What is the FDA product code for EndeavorRx?

The FDA product code for EndeavorRx is QFT.

Other Devices by Akili Interactive Labs, Inc.

Related Devices (Code: QFT)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.